The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS) - PubMed (original) (raw)
. 2010 Sep 1;19(17):3440-56.
doi: 10.1093/hmg/ddq257. Epub 2010 Jun 22.
Daniela Sau, Paola Rusmini, Alessandra Boncoraglio, Elisa Onesto, Elena Bolzoni, Mariarita Galbiati, Elena Fontana, Marianna Marino, Serena Carra, Caterina Bendotti, Silvia De Biasi, Angelo Poletti
Affiliations
- PMID: 20570967
- DOI: 10.1093/hmg/ddq257
Free article
The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS)
Valeria Crippa et al. Hum Mol Genet. 2010.
Free article
Abstract
Several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), are characterized by the presence of misfolded proteins, thought to trigger neurotoxicity. Some familial forms of ALS (fALS), clinically indistinguishable from sporadic ALS (sALS), are linked to superoxide dismutase 1 (SOD1) gene mutations. It has been shown that the mutant SOD1 misfolds, forms insoluble aggregates and impairs the proteasome. Using transgenic G93A-SOD1 mice, we found that spinal cord motor neurons, accumulating mutant SOD1 also over-express the small heat shock protein HspB8. Using motor neuronal fALS models, we demonstrated that HspB8 decreases aggregation and increases mutant SOD1 solubility and clearance, without affecting wild-type SOD1 turnover. Notably, HspB8 acts on mutant SOD1 even when the proteasome activity is specifically blocked. The pharmacological blockage of autophagy resulted in a dramatic increase of mutant SOD1 aggregates. Immunoprecipitation studies, performed during autophagic flux blockage, demonstrated that mutant SOD1 interacts with the HspB8/Bag3/Hsc70/CHIP multiheteromeric complex, known to selectively activate autophagic removal of misfolded proteins. Thus, HspB8 increases mutant SOD1 clearance via autophagy. Autophagy activation was also observed in lumbar spinal cord of transgenic G93A-SOD1 mice since several autophago-lysosomal structures were present in affected surviving motor neurons. Finally, we extended our observation to a different ALS model and demonstrated that HspB8 exerts similar effects on a truncated version of TDP-43, another protein involved both in fALS and in sALS. Overall, these results indicate that the pharmacological modulation of HspB8 expression in motor neurons may have important implications to unravel the molecular mechanisms involved both in fALS and in sALS.
Similar articles
- A role of small heat shock protein B8 (HspB8) in the autophagic removal of misfolded proteins responsible for neurodegenerative diseases.
Crippa V, Carra S, Rusmini P, Sau D, Bolzoni E, Bendotti C, De Biasi S, Poletti A. Crippa V, et al. Autophagy. 2010 Oct;6(7):958-60. doi: 10.4161/auto.6.7.13042. Epub 2010 Oct 16. Autophagy. 2010. PMID: 20699640 - Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS).
Mandrioli J, Crippa V, Cereda C, Bonetto V, Zucchi E, Gessani A, Ceroni M, Chio A, D'Amico R, Monsurrò MR, Riva N, Sabatelli M, Silani V, Simone IL, Sorarù G, Provenzani A, D'Agostino VG, Carra S, Poletti A. Mandrioli J, et al. BMJ Open. 2019 May 30;9(5):e028486. doi: 10.1136/bmjopen-2018-028486. BMJ Open. 2019. PMID: 31152038 Free PMC article. - Transcriptional induction of the heat shock protein B8 mediates the clearance of misfolded proteins responsible for motor neuron diseases.
Crippa V, D'Agostino VG, Cristofani R, Rusmini P, Cicardi ME, Messi E, Loffredo R, Pancher M, Piccolella M, Galbiati M, Meroni M, Cereda C, Carra S, Provenzani A, Poletti A. Crippa V, et al. Sci Rep. 2016 Mar 10;6:22827. doi: 10.1038/srep22827. Sci Rep. 2016. PMID: 26961006 Free PMC article. - Motoneuronal and muscle-selective removal of ALS-related misfolded proteins.
Crippa V, Galbiati M, Boncoraglio A, Rusmini P, Onesto E, Giorgetti E, Cristofani R, Zito A, Poletti A. Crippa V, et al. Biochem Soc Trans. 2013 Dec;41(6):1598-604. doi: 10.1042/BST20130118. Biochem Soc Trans. 2013. PMID: 24256261 Review. - The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol.
Kalmar B, Lu CH, Greensmith L. Kalmar B, et al. Pharmacol Ther. 2014 Jan;141(1):40-54. doi: 10.1016/j.pharmthera.2013.08.003. Epub 2013 Aug 23. Pharmacol Ther. 2014. PMID: 23978556 Review.
Cited by
- A Decade of Boon or Burden: What Has the CHIP Ever Done for Cellular Protein Quality Control Mechanism Implicated in Neurodegeneration and Aging?
Joshi V, Amanullah A, Upadhyay A, Mishra R, Kumar A, Mishra A. Joshi V, et al. Front Mol Neurosci. 2016 Oct 4;9:93. doi: 10.3389/fnmol.2016.00093. eCollection 2016. Front Mol Neurosci. 2016. PMID: 27757073 Free PMC article. Review. - Carboxyl terminus of Hsp70-interacting protein (CHIP) is required to modulate cardiac hypertrophy and attenuate autophagy during exercise.
Willis MS, Min JN, Wang S, McDonough H, Lockyer P, Wadosky KM, Patterson C. Willis MS, et al. Cell Biochem Funct. 2013 Dec;31(8):724-35. doi: 10.1002/cbf.2962. Epub 2013 Apr 2. Cell Biochem Funct. 2013. PMID: 23553918 Free PMC article. - HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy.
Cristofani R, Piccolella M, Montagnani Marelli M, Tedesco B, Poletti A, Moretti RM. Cristofani R, et al. Cell Death Dis. 2022 Nov 18;13(11):973. doi: 10.1038/s41419-022-05365-9. Cell Death Dis. 2022. PMID: 36400750 Free PMC article. - Chaperones in autophagy.
Kaushik S, Cuervo AM. Kaushik S, et al. Pharmacol Res. 2012 Dec;66(6):484-93. doi: 10.1016/j.phrs.2012.10.002. Epub 2012 Oct 8. Pharmacol Res. 2012. PMID: 23059540 Free PMC article. Review. - Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trial.
Gianferrari G, Cuoghi Costantini R, Crippa V, Carra S, Bonetto V, Pansarasa O, Cereda C, Zucchi E, Martinelli I, Simonini C, Vicini R, Fini N, Trojsi F, Passaniti C, Ticozzi N, Doretti A, Diamanti L, Fiamingo G, Conte A, Dalla Bella E, D'Errico E, Scarian E, Pasetto L, Antoniani F, Galli V, Casarotto E; Co-ALS Investigators Group; D'Amico R, Poletti A, Mandrioli J. Gianferrari G, et al. Brain Commun. 2024 Sep 5;6(5):fcae304. doi: 10.1093/braincomms/fcae304. eCollection 2024. Brain Commun. 2024. PMID: 39291166 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous